Rosacea is more than just facial redness. For many, it brings burning, bumps, visible veins, and the emotional weight of a skin condition that is hard to hide. Among the latest treatments, Soolantra (ivermectin 1% cream) has become a breakthrough option for people with papulopustular rosacea (the type that causes red bumps and pimples).

But how does Soolantra actually work? And why is it different from older treatments like metronidazole or azelaic acid? Let’s dive into the science, the clinical results, and the real benefits for patients.

Understanding Rosacea: Why Treatment Is Challenging

Rosacea is a chronic inflammatory skin condition that mainly affects the central face — cheeks, nose, forehead, and chin. It’s influenced by a mix of genetics, immune system overreaction, blood vessel changes, and environmental triggers like sunlight, heat, spicy foods, and stress.

Unlike acne, rosacea isn’t caused by clogged pores. Instead, it involves:

• An overactive immune system that drives inflammation.
• Neurovascular dysregulation, leading to flushing and redness.
• A weakened skin barrier, making the skin sensitive and reactive.

This complexity means that rosacea treatment must do more than reduce surface redness — it needs to interrupt the inflammatory cycle at multiple points.

The Role of Demodex Mites

One surprising factor in rosacea is the Demodex mite, a microscopic organism that lives in hair follicles and sebaceous glands. Everyone has them, but studies show that people with rosacea often have 15–18 times more mites than those without.

When Demodex mites overgrow:

• Their presence activates immune receptors, sparking inflammation.
• They carry bacteria like Bacillus oleronius, which trigger immune responses.
• Their movement and breakdown damage the skin barrier.

Soolantra’s Dual Mechanism: Anti-Parasitic + Anti-Inflammatory

What makes Soolantra unique is its dual action:

1. Kills Demodex mites (acaricidal effect): Ivermectin binds to nerve and muscle cell channels in mites. This paralyzes and kills them, reducing the mite population. Fewer mites mean fewer triggers for inflammation.
2. Reduces inflammation directly: It blocks the cathelicidin pathway, lowers levels of LL-37 (a protein that fuels inflammation), modulates Toll-like receptor (TLR) signaling, and suppresses NF-κB — a master switch for cytokines like TNF-α, IL-1, IL-6, and IL-8.

Together, these actions break the rosacea cycle — targeting both the cause (mites) and the effect (inflammation).

A Third Benefit: Restoring the Skin Microbiome

New research suggests Soolantra may also improve the balance of skin bacteria. In clinical studies, patients using ivermectin showed an increase in Staphylococcus epidermidis, a “good” skin bacterium with anti-inflammatory properties.

Clinical Proof: What the Trials Show

• Faster results: Improvements seen as early as 2 weeks.
• Lesion reduction: Around 65% fewer bumps and pimples after 12 weeks, compared to ~40% with placebo cream.
• Clear skin rates: Nearly 40% of patients were rated “clear” or “almost clear” at 12 weeks, versus only ~15% on placebo.
• Long-term success: After 52 weeks of continuous use, up to 76% of patients achieved clear or almost clear skin.

How to Use Soolantra Correctly

1. Apply once daily.
2. Use a pea-sized amount on each area: forehead, nose, chin, and cheeks.
3. Spread evenly across the whole face.
4. Avoid eyes, lips, and inside the nose.
5. Allow to dry before applying sunscreen or makeup.

For detailed guidance, see how to use Soolantra to minimize recurrence.

Safety and Side Effects

Soolantra is well tolerated, even for sensitive skin:

• Mild burning or irritation occurs in less than 1% of patients.
• Minimal absorption into the bloodstream makes systemic side effects rare.
• Safe for long-term use, with no buildup in the body after a year of treatment.

Soolantra vs. Other Rosacea Treatments

• Metronidazole: Works as an anti-inflammatory, but lacks anti-mite action.
• Azelaic acid: Reduces inflammation, but more likely to cause stinging or burning.
• Soolantra: Combines anti-parasitic, anti-inflammatory, and microbiome-balancing effects.

For a patient perspective, read a detailed experience treating rosacea in Australia.

FAQ: Common Questions About Soolantra

Does Soolantra cure rosacea?

No. Rosacea is a chronic condition. Soolantra helps manage symptoms and reduce flare-ups, but ongoing care is usually needed.

How long does it take for Soolantra to work?

Some patients see results in 2–4 weeks, but most notice significant improvement after 8–12 weeks of daily use.

Can Soolantra be used with other rosacea treatments?

Yes. Dermatologists often combine Soolantra with other therapies, such as oral antibiotics or laser treatments, depending on the severity of symptoms.

What if Soolantra doesn’t work for me?

Every skin is different. If you don’t see results, talk to your dermatologist about alternatives. You can also read what to do if Soolantra didn’t work.

Why is Soolantra so expensive?

Pricing depends on location, pharmacy, and insurance coverage. Learn more in our guide: Why is Soolantra so expensive?.

Can I stop using Soolantra once my skin clears?

It’s best to continue as directed by your dermatologist. Stopping treatment too early may cause rosacea symptoms to return.

Key Takeaways

• Rosacea is driven by immune overreaction, blood vessel sensitivity, and Demodex mites.
• Soolantra works by killing mites, reducing inflammation, and supporting a healthier skin microbiome.
• Clinical trials show faster, stronger, and longer-lasting results compared to older treatments.
• With its once-daily application and gentle tolerability, Soolantra is now considered a first-line option for papulopustular rosacea.

Related Reading

• Soolantra cream price 2025
• Acne or Rosacea? 5 Key Differences
• Soolantra Didn’t Work – What to Do Next

Source: 

1. Rosacea | Better Health Channel, accessed September 15, 2025, https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/rosacea
2. New developments in the treatment of rosacea – role of once-daily ivermectin cream – PMC, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4807898/
3. Ivermectin 1% (CD5024) for the treatment of rosacea – ResearchGate, accessed September 15, 2025, https://www.researchgate.net/publication/323810927_Ivermectin_1_CD5024_for_the_treatment_of_rosacea
4. Rosacea – NHS inform, accessed September 15, 2025, https://www.nhsinform.scot/illnesses-and-conditions/skin-hair-and-nails/rosacea/
5. All About Rosacea: Signs & Symptoms and Treatment, accessed September 15, 2025, https://www.rosacea.org/patients/all-about-rosacea
6. (PDF) The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis – ResearchGate, accessed September 15, 2025, https://www.researchgate.net/publication/305518692_The_efficacy_safety_and_tolerability_of_ivermectin_compared_with_current_topical_treatments_for_the_inflammatory_lesions_of_rosacea_a_network_meta-analysis
7. Rosacea | Johns Hopkins Medicine, accessed September 15, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/rosacea
8. Rosacea – NHS, accessed September 15, 2025, https://www.nhs.uk/conditions/rosacea/
9. Soolantra Vs Finacea And Other Rosacea Treatments – Which Is Best?, accessed September 15, 2025, https://www.theindependentpharmacy.co.uk/rosacea/guides/soolantra-versus-finacea
10. New developments in the treatment of rosacea – role of once-daily ivermectin cream, accessed September 15, 2025, https://www.dovepress.com/new-developments-in-the-treatment-of-rosacea-ndash-role-of-once-daily–peer-reviewed-fulltext-article-CCID
11. Current Therapies for the Management of Patients with Rosacea, accessed September 15, 2025, https://ahdbonline.com/payer-perspectives-in-dermatology/article-1470
12. Novel Rosacea Compound, Ivermectin Cream, Offers Unique Mechanism of Action, accessed September 15, 2025, https://www.ahdbonline.com/payer-perspectives-in-dermatology/novel-rosacea-compound-ivermectin-cream-offers-unique-mechanism-of-action
13. Galderma Receives FDA Approval of Novel Treatment Option for Rosacea Patients, accessed September 15, 2025, https://www.galderma.com/us/news/galderma-receives-fda-approval-novel-treatment-option-rosacea-patients
14. Soolantra: Uses, side effects, generic, how to use, and more – Medical News Today, accessed September 15, 2025, https://www.medicalnewstoday.com/articles/soolantra
15. Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea – PMC – PubMed Central, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4665052/
16. Soolantra Cream – NPS MedicineWise, accessed September 15, 2025, https://www.nps.org.au/medicine-finder/soolantra-cream
17. Full evidence summary | Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream | Advice | NICE, accessed September 15, 2025, https://www.nice.org.uk/advice/esnm68/chapter/full-evidence-summary
18. New developments in the treatment of rosacea – role of once-daily ivermectin cream, accessed September 15, 2025, https://www.researchgate.net/publication/299135889_New_developments_in_the_treatment_of_rosacea_-_role_of_once-daily_ivermectin_cream
19. Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis – PubMed, accessed September 15, 2025, https://pubmed.ncbi.nlm.nih.gov/37801528/
20. Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis – JDDonline – Journal of Drugs in Dermatology, accessed September 15, 2025, https://jddonline.com/articles/topical-ivermectin-is-associated-with-improved-erythematotelangiectatic-papulopustular-and-phymatous-rosacea-in-a-secondary-analysis-S1545961623P1063X/
21. Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea – PMC, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5749619/
22. Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models | springermedizin.de, accessed September 15, 2025, https://www.springermedizin.de/topical-treatment-of-rosacea-with-ivermectin-inhibits-gene-expre/12096844
23. Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments – PMC, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5020118/
24. New indications for topical ivermectin 1% cream: a case series study – PubMed Central, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6409879/
25. Causes of Rosacea: Demodex Mites & Microbes, accessed September 15, 2025, https://www.rosacea.org/patients/causes-of-rosacea/demodex-mites-and-microbes
26. Demodex Mites and Rosacea: Understanding the Connection and How to Treat It Effectively, accessed September 15, 2025, https://www.clinikally.com/blogs/news/demodex-mites-and-rosacea-connection-and-how-to-treat-it
27. Evidence for the Clinical Association between Demodex and Rosacea: A Review, accessed September 15, 2025, https://karger.com/drm/article/240/1/95/866652/Evidence-for-the-Clinical-Association-between
28. The connection between Demodex Mites and Rosacea | The Derm NP, accessed September 15, 2025, https://thedermnp.com/the-connection-between-demodex-mites-and-rosacea/
29. Demodex and rosacea: Is there a relationship? – PMC, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5778578/
30. Topical Ivermectin May Improve Rosacea Indirectly, accessed September 15, 2025, https://www.rosacea.org/blog/2025/january/topical-ivermectin-may-improve-rosacea-indirectly
31. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? – PubMed Central, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7649190/
32. Efficacy and Safety of Ivermectin 1% Cream in Treatment of Papulopustular Rosacea: Results of Two Randomized, Double-Blind, Vehicle-Controlled Pivotal Studies – JDDonline – Journal of Drugs in Dermatology, accessed September 15, 2025, https://jddonline.com/articles/efficacy-and-safety-of-ivermectin-1-cream-in-treatment-of-papulopustular-rosacea-results-of-two-rand-S1545961614P0316X/?_page=7
33. Ivermectin 1% Cream | Article | NursingCenter, accessed September 15, 2025, https://www.nursingcenter.com/journalarticle?Article_ID=4224244&Journal_ID=849729&Issue_ID=4224020
34. Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy – PubMed, accessed September 15, 2025, https://pubmed.ncbi.nlm.nih.gov/38606261/
35. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea – PubMed, accessed September 15, 2025, https://pubmed.ncbi.nlm.nih.gov/28653460/
36. Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea – ResearchGate, accessed September 15, 2025, https://www.researchgate.net/publication/321107229_Topical_Ivermectin_Data_Supporting_Dual_Modes_of_Action_in_Rosacea
37. (PDF) Papulopustular rosacea treated with ivermectin 1% cream: remission of the Demodex mite infestation over the time and evaluation of clinical relapses – ResearchGate, accessed September 15, 2025, https://www.researchgate.net/publication/365044371_Papulopustular_rosacea_treated_with_ivermectin_1_cream_remission_of_the_Demodex_mite_infestation_over_the_time_and_evaluation_of_clinical_relapses
38. Minocycline inhibits rosacea-like inflammation through the TLR4-mediated NF-κB signaling pathway in vivo and in vitro | PLOS One – Research journals, accessed September 15, 2025, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0323598
39. Soolantra Patient Tips: 7 things you should know – Drugs.com, accessed September 15, 2025, https://www.drugs.com/tips/soolantra-patient-tips
40. 2 Elements for a public summary VI.2.1 Overview of disease epidemiology Soolantra® is a cream intended for the cutaneous tr, accessed September 15, 2025, https://laegemiddelstyrelsen.dk/upload/rmp/28105412314%2022-03-2015.pdf
41. Investigational Agent Clears Papulopustular Rosacea by Tackling an Underlying Cause, accessed September 15, 2025, https://ahdbonline.com/payer-perspectives-in-dermatology/investigational-agent-clears-papulopustular-rosacea-by-tackling-an-underlying-cause
42. SOOLANTRA™(ivermectin) cream – accessdata.fda.gov, accessed September 15, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206255lbl.pdf
43. P52476-2 Soolantra cream PI Marketing – Galderma, accessed September 15, 2025, https://www.galderma.com/us/sites/default/files/2019-01/Soolantra%20Cream%20PI.pdf
44. 206255Orig1s000 – accessdata.fda.gov, accessed September 15, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206255Orig1s000MedR.pdf
45. Topical treatments for rosacea – PMC, accessed September 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6853348/
46. Common Drug Review, accessed September 15, 2025, https://www.cda-amc.ca/sites/default/files/cdr/clinical/SR0429_Rosiver_CL_Report.pdf
47. Azelaic Acid Topical vs Soolantra Comparison – Drugs.com, accessed September 15, 2025, https://www.drugs.com/compare/azelaic-acid-topical-vs-soolantra
48. 206255Orig1s000 – accessdata.fda.gov, accessed September 15, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206255Orig1s000ClinPharmR.pdf
49. SOOLANTRA® Cream, accessed September 15, 2025, https://www.nps.org.au/assets/medicines/645e9dd6-f979-4c58-a6a2-a53900d285cb.pdf
50. Ivermectin (topical application route) – Side effects & dosage – Mayo Clinic, accessed September 15, 2025, https://www.mayoclinic.org/drugs-supplements/ivermectin-topical-application-route/description/drg-20075441
51. Soolantra (Ivermectin): Uses, Side Effects, FAQs & More – GoodRx, accessed September 15, 2025, https://www.goodrx.com/soolantra/what-is